Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status

Overview of attention for article published in Cancer Cell International, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#27 of 1,792)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Dimensions has found 30 publications that cite this research output.

Article in Journal of Nanobiotechnology (October 2023)

Article in Pharmacological Research (September 2023)

Preprint in Research Square (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.